BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11192849)

  • 21. Human immunodeficiency virus type 1 envelope-stimulated interleukin-2 production and survival of infected children with severe and mild clinical disease.
    Kuhn L; Meyers TM; Meddows-Taylor S; Simmank K; Sherman GG; Tiemessen CT
    J Infect Dis; 2001 Sep; 184(6):691-8. PubMed ID: 11517429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals.
    Clerici M; Lucey DR; Zajac RA; Boswell RN; Gebel HM; Takahashi H; Berzofsky JA; Shearer GM
    J Immunol; 1991 Apr; 146(7):2214-9. PubMed ID: 1826020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
    Clerici M; Stocks NI; Zajac RA; Boswell RN; Lucey DR; Via CS; Shearer GM
    J Clin Invest; 1989 Dec; 84(6):1892-9. PubMed ID: 2574188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire.
    Ryder RW; Nsa W; Hassig SE; Behets F; Rayfield M; Ekungola B; Nelson AM; Mulenda U; Francis H; Mwandagalirwa K
    N Engl J Med; 1989 Jun; 320(25):1637-42. PubMed ID: 2786145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
    Pinto LA; Sullivan J; Berzofsky JA; Clerici M; Kessler HA; Landay AL; Shearer GM
    J Clin Invest; 1995 Aug; 96(2):867-76. PubMed ID: 7635981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
    JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire.
    Jennes W; Vuylsteke B; Borget MY; Traore-Ettiegne V; Maurice C; Nolan M; Nkengasong JN; Kestens L
    J Infect Dis; 2004 Feb; 189(4):602-10. PubMed ID: 14767812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau.
    Andreasson PA; Dias F; Nauclér A; Andersson S; Biberfeld G
    AIDS; 1993 Jul; 7(7):989-93. PubMed ID: 8357558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.
    Malhotra U; Holte S; Zhu T; Delpit E; Huntsberry C; Sette A; Shankarappa R; Maenza J; Corey L; McElrath MJ
    J Virol; 2003 Feb; 77(4):2663-74. PubMed ID: 12552005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.
    Clerici M; Levin JM; Kessler HA; Harris A; Berzofsky JA; Landay AL; Shearer GM
    JAMA; 1994 Jan; 271(1):42-6. PubMed ID: 8258885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.
    Clerici M; Stocks NI; Zajac RA; Boswell RN; Bernstein DC; Mann DL; Shearer GM; Berzofsky JA
    Nature; 1989 Jun; 339(6223):383-5. PubMed ID: 2524668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and magnitude of human immunodeficiency virus (HIV) type 1-specific lymphocyte responses in breast milk from HIV-1-seropositive women.
    Lohman BL; Slyker J; Mbori-Ngacha D; Bosire R; Farquhar C; Obimbo E; Otieno P; Nduati R; Rowland-Jones S; John-Stewart G
    J Infect Dis; 2003 Dec; 188(11):1666-74. PubMed ID: 14639537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission.
    Lohman-Payne B; Slyker JA; Moore S; Maleche-Obimbo E; Wamalwa DC; Richardson BA; Rowland-Jones S; Mbori-Ngacha D; Farquhar C; Overbaugh J; John-Stewart G
    AIDS; 2012 Oct; 26(16):2007-16. PubMed ID: 22948269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection.
    Clerici M; Tacket CO; Via CS; Lucey DR; Muluk SC; Zajac RA; Boswell RN; Berzofsky JA; Shearer GM
    Eur J Immunol; 1991 Jun; 21(6):1345-9. PubMed ID: 1845391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic implication of specific immunoglobulin G patterns of children born to HIV-infected mothers.
    Broliden PA; Moschese V; Ljunggren K; Rosen J; Fundaro C; Plebani A; Jondal M; Rossi P; Wahren B
    AIDS; 1989 Sep; 3(9):577-82. PubMed ID: 2551341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytohemagglutinin-inducible p24 in peripheral blood mononuclear cells as a predictor of human immunodeficiency virus type 1 vertical transmission and infant clinical status.
    Farley JJ; Bauer G; Johnson JP; Cole GA
    Pediatr Infect Dis J; 1994 Dec; 13(12):1079-82. PubMed ID: 7892074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunity to measles in pregnant mothers and in cord blood of their infants: impact of HIV status and mother's place of birth.
    Choudhury SA; Hatcher F; Berthaud V; Ladson G; Hills E; Humphrey A
    J Natl Med Assoc; 2008 Dec; 100(12):1445-9. PubMed ID: 19110913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymptomatic women at high risk of vertical HIV-1 transmission to their fetuses.
    Tibaldi C; Tovo PA; Ziarati N; Palomba E; Salassa B; Sciandra M; D'Ambrosio R; Ponti A; Sinicco A
    Br J Obstet Gynaecol; 1993 Apr; 100(4):334-7. PubMed ID: 8098619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi.
    Ioannidis JP; Taha TE; Kumwenda N; Broadhead R; Mtimavalye L; Miotti P; Yellin F; Contopoulos-Ioannidis DG; Biggar RJ
    Int J Epidemiol; 1999 Aug; 28(4):769-75. PubMed ID: 10480709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group.
    Blanche S; Rouzioux C; Moscato ML; Veber F; Mayaux MJ; Jacomet C; Tricoire J; Deville A; Vial M; Firtion G
    N Engl J Med; 1989 Jun; 320(25):1643-8. PubMed ID: 2657430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.